Alphanumeric

02/28/2026

Today is Rare Disease Day, a global movement to raise awareness for the 300 million people worldwide living with a rare condition. At Alphanumeric, we know that for these patients, every interaction matters and every second counts.

Innovation in life sciences isn’t just about the blockbuster drugs; it’s about the precision, the personalized care, and the digital tools that bridge the gap between a diagnosis and a better quality of life.

We are proud to partner with organizations that prioritize the patient voice, ensuring that no one is left behind in the pursuit of medical progress.

01/29/2026

On January 30, Alphanumeric is honored to be part of a delegation from the State of North Carolina, co-sponsoring an exclusive life sciences event at the Bellevue Palace Hotel in Bern, alongside the North Carolina Biotechnology Center and the Research Triangle Regional Partnership.

This event is designed for life science companies exploring U.S. expansion, offering direct insight into why North Carolina is one of the most established and fastest-growing life sciences hubs in the world—from R&D and clinical operations to manufacturing and commercialization.

Attendees will gain:
✔️ A clear view of North Carolina’s life sciences ecosystem
✔️ Insights into incentives, talent, and infrastructure
✔️ Direct access to economic development and industry experts
✔️ Practical guidance on setting up and scaling U.S. operations

We look forward to connecting with innovators shaping the future of life sciences and exploring how North Carolina can support your next phase of growth.

01/20/2026

From Idea to IND: A Practical Roadmap for Early-Stage Pharma Startups

Bringing a scientific concept to IND doesn’t have to be overwhelming. Our latest blog breaks down a clear, step-by-step checklist to help early-stage pharma and biotech teams move from idea to IND with confidence—while strengthening scientific rigor, regulatory alignment, and investor readiness.

From validating your scientific rationale and defining a strong Target Product Profile to IND-enabling studies, CMC strategy, regulatory engagement, and first-in-human readiness, this guide outlines what matters most at each stage—and how to integrate development with effective scientific and investor communications.

If IND is on your roadmap this year, this is a must-read.

Read the full blog and learn how Alphanumeric helps startups move faster, smarter, and with confidence—from strategy to IND and beyond.

Step-by-step guide for early-stage pharma startups to navigate the path from concept to IND submission efficiently and successfully.

01/19/2026

On Martin Luther King Jr. Day, we reflect on the values of compassion, integrity, and progress. At Alphanumeric, these principles guide how our people collaborate, innovate, and support the Life Sciences community in improving lives around the world.

01/01/2026

Every new year begins like a new moon—full of possibility. 🌑

As the year unfolds, each phase brings growth, momentum, and clarity. At Alphanumeric, we partner with Life Sciences and Healthcare organizations through every stage—helping turn vision into measurable impact.

Here’s to a year of progress, innovation, and shared success. Happy New Year.

11/27/2025

This Thanksgiving, we’re thankful for the people who make what we do meaningful — our clients, partners, and teammates.

Your trust and collaboration inspire us every day to keep innovating, connecting, and delivering with purpose.

From all of us at Alphanumeric, have a safe and happy Thanksgiving!

11/19/2025

Growth requires the right voices behind you.

Alphanumeric’s KOL engagement strategies connect startups with the right experts early—through advisory boards, publications, and collaborations. The result? Credibility, advocacy, and momentum.

Let’s discuss how we can guide you from concept to commercialization.

11/11/2025

Honoring those who served.

Today, we pause to thank the brave men and women who have served our country with courage, dedication, and sacrifice.

Your commitment to protecting freedom inspires us to bring that same integrity and purpose into everything we do.

From all of us at Alphanumeric — thank you for your service.

11/05/2025

From INDs to manuscripts, early-stage Life Sciences companies need clear, compliant communications to gain visibility and trust.

Our Regulatory Writing ensures approvals stay on track, while our Medical Writing translates complex science into credibility with investors, KOLs, and the scientific community.

Ready to strengthen your communications? Connect with us today.

10/14/2025

Early-stage Life Sciences startups face their toughest challenges at the start: limited capital, complex regulations, and the need to prove credibility fast.

At Alphanumeric, we help you shine brighter with grant writing, regulatory support, and communication strategies that build trust with investors, regulators, and partners.

Let’s talk about how we can support your next phase.

10/10/2025

Thank you to Fierce Pharma for hosting a fantastic Fierce Biotech Week! Team Alphanumeric appreciated the opportunity to connect with biotech and life sciences leaders who are driving innovation. We’re looking forward to continuing these conversations and we’re excited to see where the industry heads next.

Learn more about how Alphanumeric supports innovation in biotech and life sciences: https://hubs.ly/Q03LpY-K0

10/06/2025

Just as the moon evolves through its phases, so does innovation—and so does Alphanumeric.
We’re proud to unveil our new website, https://bit.ly/4mU4tBD, designed to reflect our journey of growth, transformation, and the limitless possibilities ahead. Inspired by the rhythm of the moon, our refreshed look mirrors the cycles of progress we help Life Science companies navigate every day.
Take a look around—we think you’ll like what you see.